Growing community of inventors

Pittsburgh, PA, United States of America

Orest Taras Macina

Average Co-Inventor Count = 5.57

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 114

Orest Taras MacinaDingwei Tim Yu (10 patents)Orest Taras MacinaYoshitaka Konishi (6 patents)Orest Taras MacinaSung J Lee (6 patents)Orest Taras MacinaKigen Kondo (6 patents)Orest Taras MacinaJagadish C Sircar (4 patents)Orest Taras MacinaIla Sircar (4 patents)Orest Taras MacinaChristopher Mark Riviello (4 patents)Orest Taras MacinaManton Rodgers Frierson (3 patents)Orest Taras MacinaMasafumi Sugitani (3 patents)Orest Taras MacinaTamara A Miskowski (1 patent)Orest Taras MacinaOrest Taras Macina (10 patents)Dingwei Tim YuDingwei Tim Yu (10 patents)Yoshitaka KonishiYoshitaka Konishi (16 patents)Sung J LeeSung J Lee (13 patents)Kigen KondoKigen Kondo (6 patents)Jagadish C SircarJagadish C Sircar (67 patents)Ila SircarIla Sircar (45 patents)Christopher Mark RivielloChristopher Mark Riviello (9 patents)Manton Rodgers FriersonManton Rodgers Frierson (4 patents)Masafumi SugitaniMasafumi Sugitani (3 patents)Tamara A MiskowskiTamara A Miskowski (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ono Pharmaceutical Co., Ltd. (6 from 575 patents)

2. Other (4 from 832,880 patents)


10 patents:

1. 6380187 - Class of thiomorpholino substituted thiazoles

2. 6281217 - Class of piperazino substituted thiazoles

3. 6277873 - Oxadiazole antifungal agents

4. 6156776 - Diaryl substituted thiazoles useful in the treatment of fungal infections

5. 6114338 - Heterocyclic compounds

6. 6001830 - Heterocyclic compounds

7. 5869486 - Fused pyrimidines and pyriazines as pharmaceutical compounds

8. 5525604 - 4-aminopyrimidine derivatives

9. 5439895 - 4-aminoquinazoline derivatives

10. 5436233 - 4-aminoquinazoline derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…